Earnings Call · Q2 FY2022·2022-08-07

Q2 22EPS +77.23%·Rev n/aQ1 22EPS -8.51%·Rev n/aQ4 21EPS +57.14%·Rev n/aQ3 21EPS -23.38%·Rev n/a⚠ consensus missing

CYTOKINETICS INC CYTK

Diane Weiser — Investor Relations

Robert Blum — President and Chief Executive Officer

Fady Malik — Executive Vice President, Research and Development

Andrew Callos — Executive Vice President, Commercial

Stuart Kupfer — Senior Vice President, Clinical Development

Robert Wong — Chief Accounting Officer

Ching Jaw — Chief Financial Officer

+10.9%1d on move date+11.1% vs SPY3d+12.4%5d+5.9%

Research tier

Behavioral profile computed for 7 speakers on this call.

Sign in to view the Behavioral Lean, the Behavioral Deviation Score, the speaker decomposition, and the novel forward-guidance phrases flagged on this call — each scored against the speaker's own prior-call baseline.

Behavioral data on every earnings call

Per-speaker language deviation, scored against each executive's own history. Explore more CYTK calls or request research access.

More CYTK calls Browse calls Request research access